James Loerop
Chief Business Officer · 5 filings · Latest: Feb 3, 2026
Aclaris Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
ACRS | James Loerop | Chief Business Officer | Feb 3, 2026 | Option Exercise | — | 20,875 | — | 198,197 | |
ACRS | James Loerop | Chief Business Officer | Feb 1, 2026 | Option Exercise | — | 33,500 | — | 188,008 | |